BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jun 01, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Everolimus: Preliminary Phase I data

Preliminary data from 31 evaluable patients in an ongoing, dose-escalation Phase I trial showed that everolimus resulted in 10 (61%, n=16) cases of stable disease in patients receiving 2.5-10 mg daily and 7 (47%, n=15) cases of stable disease in patients...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >